Synergy Pharma (SGYP) Adds to Gains as Analyst Stokes Speculation Fire

September 15, 2016 11:02 AM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Synergy Pharma (NASDAQ: SGYP) is adding to recent gains after Citi highlighted the company as a biotech takeover target for Takeda yesterday. Share are up 8.5% after jumping 8.8% yesterday. Volume is running 4x normal.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Momentum Movers, Rumors, Trader Talk

Related Entities

Citi

Add Your Comment